Retinopathy of prematurity: a review of epidemiology and current treatment strategiesopen access
- Authors
- Hong, Eun Hee; Shin, Yong Un; Cho, Hee Yoon
- Issue Date
- Mar-2022
- Publisher
- Korean Pediatric Society
- Keywords
- Epidemics; Laser; Retinopathy of prematurity; Vascular endothelial growth factor; Vitrectomy
- Citation
- Clinical and Experimental Pediatrics, v.65, no.3, pp.115 - 126
- Indexed
- SCOPUS
KCI
- Journal Title
- Clinical and Experimental Pediatrics
- Volume
- 65
- Number
- 3
- Start Page
- 115
- End Page
- 126
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/139174
- DOI
- 10.3345/cep.2021.00773
- ISSN
- 2713-4148
- Abstract
- Retinopathy of prematurity (ROP) is among the most common causes of childhood blindness. Three phases of ROP epidemics have been observed worldwide since ROP was first described in the 1940s. Despite advances in neonatal care, the occurrence of ROP and associated visual impairment has been increasing somewhere on Earth and remains difficult to control. Conventional treatment options for preventing ROP progression include retinal ablation using cryotherapy or laser therapy. With the emergence of anti-vascular endothelial growth factor (anti-VEGF) treatment for ocular diseases, the efficacy and safety of anti-VEGF therapy for ROP have recently been actively discussed. In the advanced stage of ROP with retinal detachment, surgical treatment including scleral buckling or vitrectomy is needed to maintain or induce retinal attachment. At this stage, the visual outcome is usually poor despite successful anatomical retinal attachment. Therefore, preventing ROP progression by timely screening examinations and treatment remains the most important part of ROP management.
- Files in This Item
-
- Appears in
Collections - 서울 의과대학 > 서울 안과학교실 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/139174)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.